- U.S. To J&J: Don’t Target Hospital Drug Discounts The Wall Street Journal
- HRSA orders J&J to drop controversial 340B rebate model Modern Healthcare
- U.S. agency threatens J&J with sanctions if it switches payments to 340B hospitals STAT
- The 340B Drug Pricing Program: Top Five Things to Know
[ad_2]
Source link